Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia–reperfusion injury

Fig. 4

VEGF-B inhibited H/R-induced H9c2 cell apoptosis in vitro. a pAkt, pERK1 and pp38MAPK expression was detected using western blot, as described in the “Methods” section (b), and quantified via normalization to a-tubulin (bd). *P < 0.05 vs. 15 % FBS-treated cells; # P < 0.05 vs. H/R-treated cells; @ P < 0.05 vs. 0.1 ng/ml VEGF-B-treated cells; $ P < 0.05 vs. 1.0 ng/ml VEGF-B-treated cells; & P < 0.05 vs. 10 ng/ml VEGF-B-treated cells; ^ P < 0.05 vs. 20 ng/ml VEGF-B-treated cells, n = 6. e Cell apoptosis was detected using Annexin V/PI staining, n = 6. f Quantitative analysis of cell apoptosis in (e). *P < 0.05 vs. 15 % FBS-treated cells; # P < 0.05 vs. H/R-treated cells; @ P > 0.05 vs. H/R-treated cells; $ P > 0.05 vs. H/R-treated cells; & P < 0.05 vs. H/R-treated cells; ^ P < 0.05 vs. 20 ng/ml VEGF-B-treated cells, n = 6

Back to article page